IGF1 can greatly enhance the bioactivity of human-derived mesenchymal stem cells and activate the PI3K/Akt signalling pathway to play a protective role against hypoxia and nutrient deficiency, thus providing guarantee for mesenchymal stem cells to treat IDD [35]. This evidence concerns the gene IGF1 and hyperinsulinemic hypoglycemia, familial, 4.